Federal Reserve Chair Nomination Hearing Delayed
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 10 2026
0mins
Should l Buy EL?
Source: seekingalpha
- Hearing Delay: The nomination hearing for Federal Reserve Chair candidate Kevin Warsh, originally scheduled for April 16, has been delayed due to the committee's failure to receive his financial disclosure documents, highlighting uncertainties in the nomination process.
- Committee Rules: The committee's rules require a week's notice before the hearing, and the lack of submitted paperwork from Warsh has prevented formal notification, potentially impacting the transition of leadership at the Federal Reserve.
- Current Chair's Term: Jerome Powell's term as Federal Reserve Chair is set to end in May, and the delay in Warsh's nomination could affect market expectations regarding the continuity of Fed policies, increasing market volatility.
- Personal Background Impact: Warsh is married to Jane Lauder, an heir to Estée Lauder with an estimated net worth of $1.9 billion, which may attract public and media scrutiny during the nomination process, further influencing the political dynamics surrounding his candidacy.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EL
Wall Street analysts forecast EL stock price to rise
18 Analyst Rating
8 Buy
9 Hold
1 Sell
Moderate Buy
Current: 76.140
Low
70.00
Averages
106.76
High
130.00
Current: 76.140
Low
70.00
Averages
106.76
High
130.00
About EL
The Estee Lauder Companies Inc. is a manufacturer, marketer and seller of skin care, makeup, fragrance and hair care products. Its products are sold in over 150 countries and territories under a number of brand names, including Estee Lauder, Aramis, Clinique, Lab Series, Origins, M.A.C, Bobbi Brown Cosmetics, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, Kilian Paris, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty. It is a licensee for fragrances, cosmetics and/or related products for AERIN, BALMAIN, and Dr. Andrew Weil. Its skin care products include moisturizers, serums, cleansers, toners, exfoliators, facial masks, body care, sun care products and others. Its makeup products include foundations, powders, concealers and setting sprays, lipsticks, lip liners and lip glosses, and mascaras, eyeshadows and eyeliners.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Merger Negotiation Update: Estee Lauder's CEO stated at the FT Business of Luxury Summit in Apulia, Italy, that discussions with Puig regarding a potential merger are ongoing, although no formal announcement has been made, indicating the company's proactive approach to expanding market share.
- Brand Integration Potential: The potential merger could consolidate several renowned brands, including Tom Ford, Carolina Herrera, Rabanne, Jean Paul Gaultier, and Clinique, which may significantly enhance Estee Lauder's competitiveness in the premium beauty market.
- Importance of Acquisition Strategy: The CEO emphasized that acquisitions have long been part of Estee Lauder's strategy, noting that while organic growth remains paramount, inorganic growth is essential for diversification into new geographies and categories, highlighting the company's commitment to future expansion.
- Market Reaction Expectations: Although there is currently no specific timeline for the merger, the ongoing negotiations may trigger positive market reactions in the future, boosting investor confidence in Estee Lauder's long-term growth potential.
See More
- Strike Action: Workers at Puig's Vacarisses cosmetics factory near Barcelona will hold a 24-hour strike on May 20 due to pay disparities among employee groups, reflecting strong employee demands for wage equity.
- Union Involvement: The CGT union stated that this strike aims to draw management's attention to the issue of pay inequality, which could impact the factory's production efficiency and the company's reputation, thereby negatively affecting Puig's operations.
- Merger Negotiations: Puig is in talks with U.S. cosmetics group Estée Lauder over a potential merger that could create one of the world's largest beauty companies, significantly altering the market landscape and enhancing competitive strength for both parties.
- Market Impact: The simultaneous occurrence of the strike and merger negotiations may affect investor confidence, particularly at a critical time when Puig seeks to expand its market share through the merger.
See More
- Doubling Restaurant Count: Gourmet Investments aims to increase its restaurant count from approximately 55 to 100-125 over the next three years, demonstrating strong confidence in the Indian market despite global inflation pressures on consumer spending.
- Brand Launch: The company plans to introduce the Olive Garden brand on Monday, with expectations to open over 10 restaurants in India within three years, targeting consumers seeking premium casual dining, particularly in large cities.
- Menu Localization: Gourmet Investments intends to retain Olive Garden's global menu while adding more vegetarian options to cater to India's large vegetarian population, a strategy that enhances brand acceptance in the local market.
- Market Competition Strategy: Despite facing fierce competition from local dining options, Gourmet Investments positions Olive Garden as a
See More
- Brand Sale Initiative: Estée Lauder is reportedly looking to sell its brands Too Faced, Smashbox, and Dr. Jart, with Too Faced and Smashbox likely sold together while Dr. Jart is expected to be sold individually, which could significantly impact the company's brand portfolio and market positioning.
- Buyer Interest: Sources indicate at least one interested buyer for Too Faced and Smashbox, while several others are considering Dr. Jart, suggesting ongoing market demand for these brands that could generate substantial cash flow for Estée Lauder.
- Merger Negotiation Progress: Puig's CEO confirmed ongoing acquisition talks with Estée Lauder, although no final decision has been made, which may influence Estée Lauder's strategic direction and future growth prospects.
- Financial Performance Impact: In its latest earnings report, Estée Lauder noted a double-digit sales decline for Too Faced in the fiscal third quarter, contributing to flat sales for the parent company's makeup business, potentially accelerating the brand sale initiative to improve overall performance.
See More
- Strong Performance: Estée Lauder reported Q1 revenue of $3.71 billion, surpassing analyst expectations of $3.70 billion with a year-on-year growth of 4.6%, reflecting robust growth in fragrance and online sales, particularly in China and emerging markets.
- Profitability Boost: Adjusted EPS reached $0.91, significantly exceeding the $0.65 forecast by analysts, marking a 40.4% increase, while adjusted EBITDA stood at $758 million, above the expected $620.8 million, showcasing the company's success in cost control and efficiency improvements.
- Market Share Gains: The CEO highlighted that three out of four regions achieved organic growth, with notable share gains in China and the U.S., indicating the company's strengthening competitive position in global markets.
- Strategic Realignment: The company is “rightsizing” its exposure in underperforming channels and reallocating resources to high-growth channels like Amazon and Sephora, which is expected to further drive growth and enhance market share in the future.
See More
- Trademark Dispute: Zara has denied infringing Estee Lauder's Jo Malone trademark in UK High Court filings, asserting that its collaboration with Malone aligns with principles established in 2020, demonstrating its commitment to legal compliance.
- Historical Context: Estee Lauder acquired Malone's perfume brand and the rights to her name in 1999, with Malone leaving in 2006 to launch her new brand, 'Jo Loves', providing crucial context for the ongoing legal dispute.
- Defense Highlights: Zara's defense indicates that Estee Lauder complained in 2020 about Zara's use of 'Jo Malone' on social media, but their lawyers later confirmed this usage was within permissible limits, suggesting Zara's practices are legally sound.
- Pricing Comparison: Zara's perfumes are priced at £35.99 per 100ml, while Jo Malone's start at £122 for the same volume, indicating a potential impact on consumer perception regarding brand positioning and market segmentation.
See More









